Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
Chronic Kidney Disease is a growing epidemic with 850 million people affected worldwide.
More than 5 lakh patients availed the benefit of queue-less OPD registration using this service
First release of Rs.166 crores incentives under PLI scheme for pharmaceuticals
The investment enhances Lonza’s capabilities and flexibility to support both clinical and commercial supply and will play a key role in meeting the growing market demand for bioconjugates
Through the new agreements, Cristal Therapeutics and McSAF will gain access to Lonza’s integrated bioconjugates offering and will be able to leverage Lonza’s expertise in developing and manufacturing bioconjugates
The top 15 Indian pharma players have continued to experience anaemic growth in the US market over the five years ended FY22
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.
The current ruling will assure the safety of the use of Ranitidine for Indian patients
Shilpa Medicare Ltd's finished dosage form manufacturing facility, Unit IV, situated at Pharma SEZ, Jadcherla, Telangana has received Health Canada GMP approval
Subscribe To Our Newsletter & Stay Updated
